Randomised clinical trial: the 5‐HT4 agonist revexepride in patients with gastro‐oesophageal reflux disease who have persistent symptoms despite PPI therapy
暂无分享,去创建一个
P. Malfertheiner | N. Shaheen | M. Ruth | F. Zerbib | A. Meulemans | N. Vakil | S. Troy | J. Tack | S. Dedrie | L. Thielemans | D. Johnson | P. Miner | J. Adler | L. Poole | P. Malfertheiner